Cellistic Logo
  • CDMO Services
    • Cell Line Development
    • Process Development
    • Analytical Development
    • Master Cell Banking
    • Tech Transfer
    • GMP Manufacturing
    • QC Testing
  • Platforms & Technologies
    • Allo Chassis™
    • STAR-CRISPR™
    • Pulse Cell Line Development Platform
    • Cellistic’s Echo Manufacturing Platform
  • GMP Manufacturing
    • Echo™-NK
    • Echo™-Cardio
    • Echo™-Endothelial
    • Echo™-T
  • Facility
  • Expert Insights
    • Announcements
    • Expert Opinion
    • Interviews
    • Podcasts
    • Posters
    • Webinars
  • About
    • Team
    • Careers
    • Events
Contact
Cellistic Logo
  • CDMO Services
    • Cell Line Development
    • Process Development
    • Analytical Development
    • Master Cell Banking
    • Tech Transfer
    • GMP Manufacturing
    • QC Testing
  • Platforms & Technologies
    • Allo Chassis™
    • STAR-CRISPR™
    • Pulse Cell Line Development Platform
    • Cellistic’s Echo Manufacturing Platform
  • GMP Manufacturing
    • Echo™-NK
    • Echo™-Cardio
    • Echo™-Endothelial
    • Echo™-T
  • Facility
  • Expert Insights
    • Announcements
    • Expert Opinion
    • Interviews
    • Podcasts
    • Posters
    • Webinars
  • About
    • Team
    • Careers
    • Events

Announcements

All Announcements Events Expert Opinion Interviews Podcasts Posters Webinars
Cellistic Announces Successful Certification of its GMP Facility Dedicated to iPSC-based Cell Therapies

March 12, 2026

Cellistic Announces Successful Certification of its GMP Facility Dedicated ...

Belgium, Mont-Saint-Guibert, November 21, 2024 – Cellistic®, a pioneer in iPSC-based ...

Cellistic Appoints Jason Conner as Chief Executive Officer

March 10, 2026

Cellistic Appoints Jason Conner as Chief Executive Officer

Mont-Saint-Guibert, Belgium & Leiden, Netherlands - March 10, 2026 Cellistic, a global ...

Cellistic Launches Three New iPSC-based GMP Manufacturing Platforms to advance Immuno-Oncology and Regenerative Cell Therapies

January 13, 2026

Cellistic Launches Three New iPSC-based GMP Manufacturing Platforms to ...

Belgium, Mont Saint-Guibert, 13 January 2026 – Cellistic, a global leader in allogeneic ...

Cellistic Launches Echo™ – NK Platform, a Scalable Solution for Off-the-Shelf Allogeneic Immune Cell Therapies

April 10, 2025

Cellistic Launches Echo™ – NK Platform, a Scalable Solution for ...

Belgium, Mont Saint-Guibert, April 10 – Cellistic, a pioneer in induced pluripotent stem cells ...

Cellistic Announces the Appointment of Tarran Pierfelice as New Chief Commercial Officer

March 10, 2025

Cellistic Announces the Appointment of Tarran Pierfelice as New Chief ...

Mont-Saint-Guibert, Belgium (March 10, 2025) – Cellistic is pleased to announce the ...

Cellistic launches Allo Chassis™: Ready-to-use, immune-cloaked iPSC Cell Lines facilitating cost-effective cell therapy development

February 17, 2025

Cellistic launches Allo Chassis™: Ready-to-use, immune-cloaked iPSC Cell ...

Belgium, Mont Saint-Guibert, February 17 – Cellistic, a pioneer in iPSC-based off-the-shelf ...

1 2 3 →
Cellistic Logo White
  • Services
  • Technologies
  • Cell Types
  • Facility
  • Resources
  • About
  • Contact
  • Team
  • Careers
x-twitter InBug-White-1

Rue Edouard Belin 2
1435 Mont-Saint-Guibert
Belgium

 

partnering@cellistic.com

  • Privacy Policy
  • Cookie Policy